1. Home
  2. USIO vs RANI Comparison

USIO vs RANI Comparison

Compare USIO & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Usio Inc.

USIO

Usio Inc.

HOLD

Current Price

$3.13

Market Cap

81.2M

Sector

Finance

ML Signal

HOLD

Logo Rani Therapeutics Holdings Inc.

RANI

Rani Therapeutics Holdings Inc.

BUY

Current Price

$0.59

Market Cap

84.6M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
USIO
RANI
Founded
1998
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Medicinal Chemicals and Botanical Products
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.2M
84.6M
IPO Year
1999
2021

Fundamental Metrics

Financial Performance
Metric
USIO
RANI
Price
$3.13
$0.59
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
5
Target Price
$5.92
★ $7.20
AVG Volume (30 Days)
172.1K
★ 519.6K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 57.14
EPS
★ 0.01
N/A
Revenue
★ $28,200,535.00
$1,633,000.00
Revenue This Year
$14.57
$283.19
Revenue Next Year
$11.98
$5.99
P/E Ratio
$314.00
★ N/A
Revenue Growth
12.69
★ 58.85
52 Week Low
$1.03
$0.57
52 Week High
$3.29
$2.63

Technical Indicators

Market Signals
Indicator
USIO
RANI
Relative Strength Index (RSI) 67.48 29.93
Support Level $2.15 N/A
Resistance Level N/A $0.85
Average True Range (ATR) 0.18 0.05
MACD 0.03 -0.01
Stochastic Oscillator 76.09 6.57

Price Performance

Historical Comparison
USIO
RANI

About USIO Usio Inc.

Usio Inc is a cloud-based Fintech payment processor. The company serves multiple industry verticals with technology that facilitates payment acceptance and funds disbursement in a single, full-stack ecosystem. It provides payment acceptance through multiple payment methods, including payment facilitation, prepaid card, and electronic billing products and services to businesses, merchants, and consumers. The company's reportable operating segments are Output Solutions and Merchant Services, and these segments.

About RANI Rani Therapeutics Holdings Inc.

Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.

Share on Social Networks: